A drug once designed for dengue virus, then quietly abandoned by industry, is suddenly back in the spotlight, and it may be ...

From respiratory infection to fatal neurological disease, EHV-1 demands rapid PCR diagnosis, and detection protocols impact ...

Researchers identify a shared RNA-protein interaction that could lead to broad-spectrum antiviral treatments for ...

Gilead Sciences, Inc. (NASDAQ:GILD) is one of the best affordable healthcare stocks to buy now. Gilead Sciences, Inc.

Harvard Medical School researchers have uncovered crucial insights into how an emerging class of antiviral drugs works.

Hepatitis B virus (HBV) infects more than 250 million people worldwide and can lead to chronic liver disease and liver cancer ...

Discover how a tiny RNA molecule serves as a molecular switch in viral infections, providing insights into phage biology.

Researchers at the Kanazawa University Graduate School of Medical Sciences report in PLOS Pathogens a novel role for the ...

A newly identified virus–cell hybrid structure allows viruses to spread faster and more aggressively by hitching a ride on ...

Please note that the posts on The Blogs are contributed by third parties. The opinions, facts and any media content in them are presented solely by the authors, and neither The Times of Israel nor its ...

A team of researchers from Stanford University and the Arc Institute in Palo Alto, California say they’ve created viruses with AI-designed DNA that can target and kill specific bacteria. And these ...

Ancient viruses left a legacy in your DNA. And it turns out, that legacy may be helping shape who you are. A recent international study has shown that certain bits of ancient viral DNA, long dismissed ...